DecisionView raises $9M for pharma clinical-trial software
San Francisco’s DecisionView, which sells software that helps biotech and pharmaceutical companies run clinical trials more efficiently, raised $9 million in a third round of funding. The round was led by firstVentury, a new investor joined by Partech International and Granite Ventures.
See David Hamilton’s story at LifeSciences here
Next Story: CMEA Ventures raising $400M fund
Previous Story: Foonz, easy conference calls across mobile phones
About the Author, Matt Marshall
Matt Marshall is editor and CEO of VentureBeat. Follow him on Twitter at @mmarshall, and follow VentureBeat on Twitter at @venturebeat.